Jason M Pogue

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Combination Therapy

Pseudomonas Aeruginosa

Multidrug Resistant

Top Venues

The Journal of antimicrobial chemotherapy

Open forum infectious diseases

JMIR mHealth and uHealth

This page only lists publications with an associated author ORCID identifier.

Publications

Walaiporn Wangchinda, Jason M Pogue, Visanu Thamlikitkul, Pannee Leelawattanachai, Pornpan Koomanachai, Manjunath Amit P Pai
Population pharmacokinetic/pharmacodynamic target attainment analysis of IV fosfomycin for the treatment of MDR Gram-negative bacterial infections. The Journal of antimicrobial chemotherapy 79 (6) (2024)
Walaiporn Wangchinda, Jason M Pogue, Visanu Thamlikitkul, Pannee Leelawattanachai, Pornpan Koomanachai, Manjunath Amit P Pai
Population pharmacokinetic/pharmacodynamic target attainment analysis of IV fosfomycin for the treatment of MDR Gram-negative bacterial infections. The Journal of antimicrobial chemotherapy 79 (6) (2024)
Walaiporn Wangchinda, Jason M Pogue, Visanu Thamlikitkul, Pannee Leelawattanachai, Pornpan Koomanachai, Manjunath Amit P Pai
Population pharmacokinetic/pharmacodynamic target attainment analysis of IV fosfomycin for the treatment of MDR Gram-negative bacterial infections. The Journal of antimicrobial chemotherapy (2024)
Walaiporn Wangchinda, Keith S Kaye, Twisha S Patel, Owen R Albin, Louis Saravolatz, Joshua G Petrie, Jason M Pogue
A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended β-lactam-resistant Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy 79 (6) (2024)
Walaiporn Wangchinda, Keith S Kaye, Twisha S Patel, Owen R Albin, Louis Saravolatz, Joshua G Petrie, Jason M Pogue
A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended β-lactam-resistant Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy 79 (6) (2024)
Walaiporn Wangchinda, Keith S Kaye, Twisha S Patel, Owen R Albin, Louis Saravolatz, Joshua G Petrie, Jason M Pogue
A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended β-lactam-resistant Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy (2024)
Jason M Pogue, Samuel L Aitken
Nut Cracked? Does the ACORN Trial End the Debate Surrounding Vancomycin and Piperacillin-Tazobactam Combination Therapy and Increased Risk for Acute Kidney Injury? Open forum infectious diseases 11 (1) (2023)
Jason M Pogue, Samuel L Aitken
Nut Cracked? Does the ACORN Trial End the Debate Surrounding Vancomycin and Piperacillin-Tazobactam Combination Therapy and Increased Risk for Acute Kidney Injury? Open forum infectious diseases 11 (1) (2023)
Xueliang Hua, Chen Li, Jason M Pogue, Varun S Sharma, Ilias Karaiskos, Keith S Kaye, Brian T Tsuji, Phillip J Bergen, Yan Zhu, Jiangning Song, Hsin-Hui Shen
Correction: ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study. JMIR mHealth and uHealth 8 (12) (2020)
Xueliang Hua, Chen Li, Jason M Pogue, Varun S Sharma, Ilias Karaiskos, Keith S Kaye, Brian T Tsuji, Phillip J Bergen, Yan Zhu, Jiangning Song, Hsin-Hui Shen
ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study. JMIR mHealth and uHealth 8 (12) (2020)